Learn about companies’ services and tools, to help you boost your K/TTO activity. Does your company service K/TTO activity?
Moderator: Steven Tan, Nascent Ventures B.V., Netherlands
|13:30-13:45|| Patent Information and Technology Transfer
Michel Caldana, Director of Picarré, Belgium
Patent databases are well known sources of technical and legal information commonly used in prior art searches, freedom-to-operate searches, etc. Their business content can also be advantageously exploited particularly in patent mappings to help the tech transfer specialists to identify potential licensees, business or research partners. Combined with economic, financial or more generally contextual data, patent mappings are a powerful tool for taking efficient business decisions. With experience in patent information Picarré IP counsels help the Wallonia tech transfer offices during EU and regional calls for projects and in the process of spin-off creation.
|13:45-14:00||5 Key Reasons to use Ximbio for Commercialising Research Reagents
Isobel Atkin, Senior Portfolio Manager, Ximbio, UK
Research reagents, such as antibodies, mice and cell lines are the cornerstones of basic scientific research; Ximbio is a marketplace for scientists to maximise commercial opportunities for these tools. Tech transfer offices are opting to work with Ximbio recognising its commercial reach and ability to secure physical material.
|14:00-14:15||Opportunities for EU Universities to Reach out to Japanese Partners and Potential Licensees
Luca Escoffier, Project Manager | EU-Japan Technology Transfer Helpdesk, Japan
Outline: in this talk, the Project Manager of the EU-Japan Centre for Industrial Cooperation in Tokyo, will introduce the audience to the EU-Japan Technology Transfer Helpdesk. The services of the Helpdesk aim at supporting EU and Japanese companies, universities, research centres and individuals in their steps to search for technologies and understand the mechanics of tech transfer transactions, as well as bridging the knowledge gap about current available technologies from both Japan and the EU. From the talk it will emerge that TTOs from the EU have several opportunities to interact with the Helpdesk participating to podcasts, webinars, posting their available technologies on the Helpdesk’s site, be actively involved in search for technologies received by the Helpdesk from Japanese companies, and so forth.
|14:15-14:30||NLC | The Healthtech Venture Builder
Alain Kummer, Director Scouting & Medical Affairs
NLC is the European healthtech venture builder, bringing science-based healthtech inventions to life. Due to market complexities at least 95% of healthtech inventions never reach the patient and the market, regardless of their relevance or brilliance. At NLC, we don’t accept this status quo. We call this opportunity, by bringing together the best tech, the best people, and the best capital to build life-changing healthtech ventures. We have designed a bold model to create early stage healthtech innovation. We step in when inventors need us most. We can step in because our model and mission are fully aligned to bring science to life. Our multilingual team is able to speak the languages of the many different silos. We build healthtech ventures, together with leading european research institutes, top-notch hospitals, TTO’s, entrepreneurs and global market leaders. Together, we fulfil our mission to bring science to life.
Dr Angela Miller, Senior Business Manager, LifeArc
LifeArc is a medical research charity with a 25-year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients.
LifeArc pioneers new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research.
So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance.
|14:45-15:00||Golden tips for IP protection for universities and start-ups
Eva Eulaers, Dutch Patent Attorney, V.O. Patents & Trademarks, the Netherlands
Knowledge and technology transfer centres play a key role in the valorization of research generated by universities or research institutes. Patents are a valuable instrument in protecting the potential market value of that research. V.O. Patents and Trademarks has a long-standing experience in accompanying universities and start-ups active in a broad range of technology and science in taking the right decisions with respect to the protection, exploitation and management of their IP, including IP issues in collaboration with third parties.
To claim your 15 minutes of fame, email: email@example.com